| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 0 | 629.947 | 1.055.058 |
| Total Income - EUR | - | - | - | - | - | - | - | 4 | 631.523 | 1.057.965 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 17.668 | 745.376 | 1.015.643 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -17.664 | -113.853 | 42.322 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -17.664 | -113.853 | 39.689 |
| Employees | - | - | - | - | - | - | - | 1 | 5 | 5 |
Check the financial reports for the company - Prolab Ivd S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 83.110 | 105.521 | 202.814 |
| Current Assets | - | - | - | - | - | - | - | 56.486 | 323.481 | 671.456 |
| Inventories | - | - | - | - | - | - | - | 10.455 | 137.985 | 362.574 |
| Receivables | - | - | - | - | - | - | - | 1.211 | 143.621 | 273.534 |
| Cash | - | - | - | - | - | - | - | 44.819 | 41.874 | 35.348 |
| Shareholders Funds | - | - | - | - | - | - | - | 83.725 | 264.777 | 302.986 |
| Social Capital | - | - | - | - | - | - | - | 101.389 | 396.240 | 394.025 |
| Debts | - | - | - | - | - | - | - | 55.871 | 165.332 | 572.894 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Prolab Ivd S.r.l.